Figure 1From: SWiss Atorvastatin and Interferon Beta-1b Trial In Multiple Sclerosis (SWABIMS) - rationale, design and methodology SWABIMS study design. Lab, laboratory tests; INFB-1b, Interferon beta-1b; MRI, magnetic resonance imaging, MSFC, multiple sclerosis functional composite; EDSS, Expanded Disability Status ScaleBack to article page